RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
  Constipation
  GERD
  IBS
  Inflammatory Bowel Disease
  Liver
   Hepatitis
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Liver Channel

subscribe to Liver newsletter
Latest Research : Gastroenterology : Liver

   EMAIL   |   PRINT
Nanoparticles may pose threat to hepatocytes

Apr 5, 2006 - 2:08:00 PM , Reviewed by: Priya Saxena
"We are looking at the new idea that the liver is a target for nanoparticles, and a lot more work needs to be done to assess the levels and impact of nanoparticles reaching the liver."

 
[RxPG] Researchers at the University of Edinburgh are to study the effects of nanoparticles on the liver. In a UK first, the scientists will assess whether nanoparticles –already found in pollution from traffic exhaust, but also used in making household goods such as paint, sunblock, food, cosmetics and clothes– can cause damage to the cells of the liver.

Nanoparticles are atoms and molecules 80,000 times smaller than the width of a human hair, with various properties according to their composition, which explains their widespread usage. Airborne nanoparticles present in traffic exhaust are already known to enter the lungs and affect human health.

Scientist Dr Celine Filippi explains: "In experiments carried out elsewhere to mimic environmental exposure, nanoparticles delivered into the lungs crossed the lung barrier and entered the blood. Particles in the blood can reach the liver, amongst other organs. We also know that nanoparticles directly injected into the blood for medical purposes are also likely to end up in the liver.

"We don't yet know if the nanoparticles are safely eliminated from the liver by specialised cells or whether these extremely small particles can enter the liver cells and disrupt their normal functioning. Our research will try to establish whether nanoparticles, which are set to be used increasingly in industry and the manufacture of household goods, can damage the cells of the liver."

Professor Ken Donaldson, Professor of Respiratory Toxicology at the University of Edinburgh said: "We are looking at the new idea that the liver is a target for nanoparticles, and a lot more work needs to be done to assess the levels and impact of nanoparticles reaching the liver."



Publication: University of Edinburgh
On the web: www.ed.ac.uk 

Advertise in this space for $10 per month. Contact us today.


Related Liver News
4 UCLA stem cell researchers receive CIRM Early Translational grants
Genetics defines a distinct liver disease
EASL publishes first comprehensive literature review on the burden of liver disease in Europe
NIH launches free database of drugs associated with liver injury
Genetic clues to the causes of primary biliary cirrhosis!
GCKR and PNLPA3 genetic variants acting in combination may confer susceptibility to fatty liver disease in obese children
NSF grant will aid Wayne State professors' mathematical modeling of fatty liver predictors
The economic cost of advanced liver disease
Celiac patients face potential hazard as information on cosmetic ingredients difficult to find
Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C

Subscribe to Liver Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)